Regulatory mechanism of gallic acid against advanced glycation end products induced cardiac remodeling in experimental rats

Chemico-Biological Interactions

Volumn 208, Issue 1, 2014, Pages 28-36

  Umadevi, Subramanian ^a   Gopi, Venkatachalam ^a   Elangovan, Vellaichamy ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

Advanced glycation end products; Cardiac fibrosis; Extracellular matrix; Gallic acid; NOX; RAGE

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; GALLIC ACID; GELATINASE A; GELATINASE B; LYMPHOTOXIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BODY WEIGHT; CARDIAC REMODELING; CONTROLLED STUDY; EXPERIMENTAL RAT; GAPDH GENE; GENE; GENE EXPRESSION; HEART DISEASE; HEART MUSCLE FIBROSIS; HEART PROTECTION; HEART WEIGHT; IN VITRO STUDY; MALE; MMP2 GENE; MMP9 GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TGF BETA GENE; TIMP1 GENE; TIMP2 GENE; TIMP3 GENE; UPREGULATION;

RATTUS;

ADVANCED GLYCATION END PRODUCTS; CARDIAC FIBROSIS; EXTRACELLULAR MATRIX; GALLIC ACID; NOX; RAGE;

ANIMALS; BIOLOGICAL MARKERS; BODY WEIGHT; FIBROSIS; GALLIC ACID; GLYCOSYLATION END PRODUCTS, ADVANCED; HEART; MALE; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NADPH OXIDASE; NF-KAPPA B; RATS; RATS, WISTAR; RECEPTORS, IMMUNOLOGIC; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84890278710     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2013.11.013     Document Type: Article

References (48)

1. M. Khullar, A.A. Al-Shudiefat, A. Ludke, G. Binepal, and P.K. Singal Oxidative stress: a key contributor to diabetic cardiomyopathy Can. J. Physiol. Pharmacol. 88 2010 233 240
2. M.C. Thomas Advanced glycation end products Contrib. Nephrol. 170 2011 66 74
3. D.P. Barlovic, M.C. Thomas, and K. Jandeleit-Dahm Cardiovascular disease: what's all the AGE/RAGE about? Cardiovasc. Hematol. Disord.: Drug Targets 10 2010 7 15
4. G. Basta, A.M. Schmidt, and R. De Caterina Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes Cardiovasc. Res. 63 2004 582 592 (Pubitemid 39078671)
5. R. Singh, A. Barden, T. Mori, and L. Beilin Advanced glycation end-products: a review Diabetologia 44 2001 129 146 (Pubitemid 32156196)
6. N. Ahmed Advanced glycation end products-role in pathology of diabetic complications Diabetes Res. Clin. Pract. 67 2005 3 21 (Pubitemid 40037725)
7. E.A. Friedman Advanced glycosylated end products and hyperglycemia in the pathogenesis of diabetic complications Diabetes Care 22 Suppl. 2 1999 B65 B71
8. M. Brownlee The pathobiology of diabetic complications: a unifying mechanism Diabetes 54 2005 1615 1625 (Pubitemid 40770750)
9. M.A. Zimanyi, K.M. Denton, J.M. Forbes, V. Thallas-Bonke, M.C. Thomas, F. Poon, and M.J. Black A developmental nephron deficit in rats is associated with increased susceptibility to a secondary renal injury due to advanced glycation end-products Diabetologia 49 2006 801 810 (Pubitemid 43357555)
10. S.D. Yan, A.M. Schmidt, G.M. Anderson, J. Zhang, J. Brett, Y.S. Zou, D. Pinsky, and D. Stern Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins J. Biol. Chem. 269 1994 9889 9897 (Pubitemid 24196599)
11. A.M. Schmidt, S.D. Yan, J.L. Wautier, and D. Stern Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis Circ. Res. 84 1999 489 497 (Pubitemid 29138585)
12. A.M. Schmidt, M. Hasu, D. Popov, J.H. Zhang, J. Chen, S.D. Yan, J. Brett, R. Cao, K. Kuwabara, and G. Costache Receptor for advanced glycation end products (AGEs) has a central role in vessel wall interactions and gene activation in response to circulating AGE proteins Proc. Natl. Acad. Sci. USA 91 1994 8807 8811
13. M.T. Coughlan, D.R. Thorburn, S.A. Penfold, A. Laskowski, B.E. Harcourt, K.C. Sourris, A.L. Tan, K. Fukami, V. Thallas-Bonke, P.P. Nawroth, M. Brownlee, A. Bierhaus, M.E. Cooper, and J.M. Forbes RAGE-induced cytosolic ROS promote mitochondrial superoxide generation in diabetes J. Am. Soc. Nephrol. 20 2009 742 752
14. D.H. Priscilla, and P.S. Prince Cardioprotective effect of gallic acid on cardiac troponin-T, cardiac marker enzymes, lipid peroxidation products and antioxidants in experimentally induced myocardial infarction in Wistar rats Chem. Biol. Interact. 179 2009 118 124
15. E.G. de Mejia, S. Chandra, M. Ramirez-Mares, and W. Wang Catalytic inhibition of human DNA topoisomerase by phenolic compounds in Ardisia compressa extracts and their effect on human colon cancer cells Food Chem. Toxicol. 44 2006 1191 1203 (Pubitemid 44192406)
16. V.R. Punithavathi, P.S. Prince, R. Kumar, and J. Selvakumari Antihyperglycaemic, antilipid peroxidative and antioxidant effects of gallic acid on streptozotocin induced diabetic Wistar rats Eur. J. Pharmacol. 650 2011 465 471
17. S. Shahrzad, K. Aoyagi, A. Winter, A. Koyama, and I. Bitsch Pharmacokinetics of gallic acid and its relative bioavailability from tea in healthy humans J. Nutr. 131 2001 1207 1210 (Pubitemid 32275101)
18. S. Umadevi, V. Gopi, S.P. Simna, A. Parthasarathy, S.M. Yousuf, and V. Elangovan Studies on the cardio protective role of gallic acid against AGE-induced cell proliferation and oxidative stress in H9C2 (2-1) cells Cardiovasc. Toxicol. 12 2012 304 311
19. S.I. Andreea, C. Marieta, and D. Anca AGEs and glucose levels modulate type I and III procollagen mRNA synthesis in dermal fibroblasts cells culture Exp. Diabetes Res. 2008 2008 473603
20. M.C. Thomas, C. Tikellis, W.M. Burns, K. Bialkowski, Z. Cao, M.T. Coughlan, K. Jandeleit-Dahm, M.E. Cooper, and J.M. Forbes Interactions between renin angiotensin system and advanced glycation in the kidney J. Am. Soc. Nephrol. 16 2005 2976 2984 (Pubitemid 44743495)
21. M. McNulty, A. Mahmud, and J. Feely Advanced glycation end-products and arterial stiffness in hypertension Am. J. Hypertens. 20 2007 242 247 (Pubitemid 46283356)
22. M. Montagnani Diabetic cardiomyopathy: how much does it depend on AGE? Br. J. Pharmacol. 154 2008 725 726 (Pubitemid 351821582)
23. J. Nozynski, M. Zakliczynski, D. Konecka-Mrowka, B. Nikiel, J. Mlynarczyk-Liszka, E. Zembala-Nozynska, D. Lange, M. Maruszewski, and M. Zembala Advanced glycation end products in the development of ischemic and dilated cardiomyopathy in patients with diabetes mellitus type 2 Transplant. Proc. 41 2009 99 104
24. L. van Heerebeek, A. Somsen, and W.J. Paulus The failing diabetic heart: focus on diastolic left ventricular dysfunction Curr. Diab. Rep. 9 2009 79 86
25. M. Tang, M. Zhong, Y. Shang, H. Lin, J. Deng, H. Jiang, H. Lu, Y. Zhang, and W. Zhang Differential regulation of collagen types I and III expression in cardiac fibroblasts by AGEs through TRB3/MAPK signaling pathway Cell. Mol. Life Sci. 65 2008 2924 2932
26. R. Candido, J.M. Forbes, M.C. Thomas, V. Thallas, R.G. Dean, W.C. Burns, C. Tikellis, R.H. Ritchie, S.M. Twigg, M.E. Cooper, and L.M. Burrell A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes Circ. Res. 92 2003 785 792 (Pubitemid 36457644)
27. A.H. Maass, K. Ikeda, S. Oberdorf-Maass, S.K. Maier, and L.A. Leinwand Hypertrophy, fibrosis, and sudden cardiac death in response to pathological stimuli in mice with mutations in cardiac troponin T Circulation 110 2004 2102 2109 (Pubitemid 39372486)
28. S. Rutschow, J. Li, H.P. Schultheiss, and M. Pauschinger Myocardial proteases and matrix remodeling in inflammatory heart disease Cardiovasc. Res. 69 2006 646 656 (Pubitemid 43139727)
29. A.K. Harris, J.R. Hutchinson, K. Sachidanandam, M.H. Johnson, A.M. Dorrance, D.W. Stepp, S.C. Fagan, and A. Ergul Type 2 diabetes causes remodeling of cerebrovasculature via differential regulation of matrix metalloproteinases and collagen synthesis: role of endothelin-1 Diabetes 54 2005 2638 2644 (Pubitemid 41233585)
30. S.S. Nah, I.Y. Choi, B. Yoo, Y.G. Kim, H.B. Moon, and C.K. Lee Advanced glycation end products increases matrix metalloproteinase-1, -3, and -13, and TNF-alpha in human osteoarthritic chondrocytes FEBS Lett. 581 2007 1928 1932 (Pubitemid 46628804)
31. M.C. Pustovrh, A. Jawerbaum, E. Capobianco, V. White, N. Martinez, J.J. Lopez-Costa, and E. Gonzalez Oxidative stress promotes the increase of matrix metalloproteinases-2 and -9 activities in the feto-placental unit of diabetic rats Free Radic. Res. 39 2005 1285 1293 (Pubitemid 43023793)
32. R. Tamarat, J.S. Silvestre, M. Huijberts, J. Benessiano, T.G. Ebrahimian, M. Duriez, M.P. Wautier, J.L. Wautier, and B.I. Levy Blockade of advanced glycation end-product formation restores ischemia-induced angiogenesis in diabetic mice Proc. Natl. Acad. Sci. USA 100 2003 8555 8560 (Pubitemid 36842582)
33. N.P. Kadoglou, S.S. Daskalopoulou, D. Perrea, and C.D. Liapis Matrix metalloproteinases and diabetic vascular complications Angiology 56 2005 173 189 (Pubitemid 40404472)
34. O.M. Dorchies, S. Wagner, K.M. Waldhauser, T.M. Buetler, and U.T. Ruegg Anti-fibrotic properties of green tea catechins on mouse muscle cell cultures Neuromuscul. Disord. 13 2003 639
35. J.E. Sanderson, K.B. Lai, I.O. Shum, S. Wei, and L.T. Chow Transforming growth factor-beta(1) expression in dilated cardiomyopathy Heart 86 2001 701 708
36. K. Jandeleit-Dahm, and M.E. Cooper Hypertension and diabetes: role of the renin-angiotensin system Endocrinol. Metab. Clin. North Am. 35 2006 469 490 (vii) (Pubitemid 44321946)
37. A.F. Quest, S. Ghosh, W.Q. Xie, and R.M. Bell DAG second messengers: molecular switches and growth control Adv. Exp. Med. Biol. 400A 1997 297 303
38. G.R. Drummond, S. Selemidis, K.K. Griendling, and C.G. Sobey Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets Nat. Rev. Drug Discov. 10 2011 453 471
39. J. Kuroda, T. Ago, S. Matsushima, P. Zhai, M.D. Schneider, and J. Sadoshima NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart Proc. Natl. Acad. Sci. USA 107 2010 15565 15570
40. C.E. Murdoch, M. Zhang, A.C. Cave, and A.M. Shah NADPH oxidase-dependent redox signalling in cardiac hypertrophy, remodelling and failure Cardiovasc. Res. 71 2006 208 215
41. T.M. Paravicini, and R.M. Touyz NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities Diabetes Care 31 Suppl. 2 2008 S170 S180
42. S.M. Huang, C.H. Wu, and G.C. Yen Effects of flavonoids on the expression of the pro-inflammatory response in human monocytes induced by ligation of the receptor for AGEs Mol. Nutr. Food Res. 50 2006 1129 1139
43. S. Yamagishi, K. Nakamura, and T. Matsui Regulation of advanced glycation end product (AGE)-receptor (RAGE) system by PPAR-gamma agonists and its implication in cardiovascular disease Pharmacol. Res. 60 2009 174 178
44. A. Goldin, J.A. Beckman, A.M. Schmidt, and M.A. Creager Advanced glycation end products: sparking the development of diabetic vascular injury Circulation 114 2006 597 605 (Pubitemid 44199649)
45. S. Schiekofer, M. Andrassy, J. Chen, G. Rudofsky, J. Schneider, T. Wendt, N. Stefan, P. Humpert, A. Fritsche, M. Stumvoll, E. Schleicher, H.U. Haring, P.P. Nawroth, and A. Bierhaus Acute hyperglycemia causes intracellular formation of CML and activation of ras, p42/44 MAPK, and nuclear factor kappaB in PBMCs Diabetes 52 2003 621 633 (Pubitemid 36323567)
46. J. Li, and A.M. Schmidt Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products J. Biol. Chem. 272 1997 16498 16506 (Pubitemid 27276477)
47. B. Chen, Y. Ma, R. Meng, Z. Xiong, C. Zhang, G. Chen, A. Zhang, and Y. Dong MG132, a proteasome inhibitor, attenuates pressure-overload-induced cardiac hypertrophy in rats by modulation of mitogen-activated protein kinase signals Acta Biochim. Biophys. Sin. (Shanghai) 42 2010 253 258
48. R. Khan, and R. Sheppard Fibrosis in heart disease: understanding the role of transforming growth factor-beta in cardiomyopathy, valvular disease and arrhythmia Immunology 118 2006 10 24